Cerity Partners LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 409 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cerity Partners LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$15,239,671
+26.8%
291,056
-1.5%
0.04%
+25.0%
Q1 2024$12,022,583
+20.7%
295,541
+9.7%
0.03%
-3.0%
Q4 2023$9,961,385
+3.0%
269,518
+6.4%
0.03%
-29.8%
Q3 2023$9,673,463
+3.9%
253,232
-1.9%
0.05%
+30.6%
Q2 2023$9,310,425
-4.6%
258,121
+1.0%
0.04%
+56.5%
Q1 2023$9,760,906
-33.8%
255,588
-1.4%
0.02%
-75.5%
Q4 2022$14,753,033
+5467.2%
259,280
+3769.9%
0.09%
+3033.3%
Q3 2022$265,000
+1.1%
6,700
+12.5%
0.00%0.0%
Q2 2022$262,0005,9530.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders